Product image of Linezolid Krka (Linezolid) supplied by GNH India

Linezolid Krka

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Krka (Linezolid)

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an injectable solution for intravenous use. It is employed to treat serious bacterial infections caused by Gram‑positive organisms, including skin and soft‑tissue infections, community‑acquired pneumonia, hospital‑acquired (nosocomial) pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA). It is also active against other resistant Gram‑positive strains. The drug is administered under medical supervision in hospital settings.

GNH India supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Linezolid is indicated for several serious bacterial infections affecting the respiratory tract and skin.
  • Skin and soft tissue infections: effective against susceptible Gram‑positive bacteria, improving clinical outcomes.
  • Community‑acquired pneumonia: provides rapid bacterial clearance and symptom resolution.
  • Nosocomial pneumonia: treats hospital‑acquired lung infections caused by resistant organisms.
  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: offers an alternative to glycopeptides for resistant skin and systemic infections.

How It Works

  • Linezolid binds to the 50S subunit of bacterial ribosomes, preventing formation of the initiation complex required for protein synthesis. By blocking the early stage of translation, it halts bacterial growth without affecting human ribosomes, resulting in a bacteriostatic effect against most susceptible organisms and a bactericidal effect at higher concentrations.

Side Effects

Linezolid may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools that may be self‑limiting.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Rash: skin erythema or pruritus.
  • Metallic taste: altered taste perception.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Anemia: reduced hemoglobin levels.
  • Peripheral neuropathy: sensory disturbances in extremities.
  • Lactic acidosis: metabolic disturbance with high lactate.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Optic neuritis: visual disturbances requiring prompt evaluation.

Precautions & Warnings

  • When using Linezolid, several safety considerations should be observed to minimize risks.
  • Monitor blood counts: perform regular CBC to detect thrombocytopenia or anemia.
  • Assess renal function: adjust therapy in severe renal impairment.
  • Evaluate for serotonin syndrome: avoid concomitant serotonergic drugs.
  • Limit duration of therapy: prolonged use increases risk of neuropathy.
  • Use with caution in hepatic impairment: monitor liver enzymes.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Linezolid interacts with several drug classes; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
  • Serotonergic agents (SSRIs, SNRIs, TCAs): potential serotonin syndrome.
  • Tyramine‑rich foods: possible hypertensive reaction.

Moderate Interactions (Monitor Closely)

  • Rifampin: may reduce linezolid plasma concentrations.
  • Warfarin: can alter INR, requiring close monitoring.
  • NSAIDs: increased bleeding risk.
  • Antacids: may affect absorption.
  • Carbamazepine: enzyme induction may lower linezolid levels.

Frequently Asked Questions

Linezolid Krka is an intravenous oxazolidinone antibiotic indicated for the treatment of serious Gram‑positive infections, including skin and soft‑tissue infections, community‑acquired pneumonia, hospital‑acquired (nosocomial) pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA).

Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex required for translation. This action stops bacterial growth, providing a bacteriostatic effect against most susceptible organisms and a bactericidal effect at higher concentrations.

The dosage and duration of Linezolid Krka are determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local treatment guidelines. No fixed regimen is provided here.

Linezolid is classified as pregnancy category unknown; therefore, it should be used only if the potential benefit justifies the potential risk to the fetus. Limited data exist for breastfeeding, and a risk‑benefit assessment should be performed by the healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required), and necessary import documentation.

The primary alternative for many Gram‑positive infections is vancomycin, a glycopeptide antibiotic. Linezolid offers oral and IV options, penetrates lung tissue well, and is active against strains resistant to vancomycin, but it carries a different safety profile, including risk of thrombocytopenia and serotonin syndrome.

Linezolid Krka should be stored at 2‑8 °C, kept refrigerated, protected from light, and should not be frozen or shaken. Maintain the cold chain during transport and handling to preserve product stability.

Linezolid Krka is supplied as an injectable solution for intravenous infusion. It is administered by a healthcare professional under aseptic conditions, typically over a set infusion period as directed by the prescriber.

Serious adverse events include thrombocytopenia, anemia, peripheral neuropathy, lactic acidosis, optic neuritis, and serotonin syndrome, especially when combined with serotonergic medications. Prompt monitoring of blood counts, metabolic parameters, and neurological status is essential.

Linezolid Krka is contraindicated in patients with known hypersensitivity to linezolid or any component of the formulation. It should also be avoided in individuals currently receiving monoamine oxidase inhibitors and in those with uncontrolled hypertension when consuming tyramine‑rich foods.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT